Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to…
CAMBRIDGE, Mass. & MONTREAL–(BUSINESS WIRE)–Repare Therapeutics Inc. (“Repare” or the “Company”) announced today the completion of the previously announced acquisition…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–$QNCX #biotech–Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of…
DUBLIN–(BUSINESS WIRE)–The “Orphan Drugs Service Market Report 2025” has been added to ResearchAndMarkets.com’s offering. The global orphan drugs service market…
This Important Milestone Represents the Initiation of the Final Development Phase Before Commercial Approval LOWELL, Mass.–(BUSINESS WIRE)–#BoneRepair–RevBio, Inc., announced that…
PRINCETON, N.J.–(BUSINESS WIRE)–Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors, announced today…
TURIN, Italy–(BUSINESS WIRE)–Reply [EXM, STAR: REY] today announced the start of a collaboration with the Department of Pathophysiology and Transplantation…
CancerVision provides tumor genomic profiling, while MRDVision enables ultra-sensitive monitoring of treatment response throughout dose escalation SAN DIEGO–(BUSINESS WIRE)–Inocras, a…
Delivering Deeper Patient Insights for Better Clinical Trials RALEIGH, N.C.–(BUSINESS WIRE)–Univo IRB today announced a partnership with The Patient View…
Life Sciences Industry Veteran Joins Convergent to Drive Strategic Growth as the Company Works to Advance its Lead Clinical Program…